| |
| |
|
| Insider
Information: |
Boyd Steven |
| Relationship: |
10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
18 |
|
| Direct
Shares |
47,075,098 |
|
|
Indirect Shares
|
40,287,245 |
|
|
| Direct
Value |
$128,455,406 |
|
|
|
Indirect Value
|
$40,265,984 |
|
|
| Total
Shares |
87,362,343 |
|
|
| Total
Value |
$168,721,391 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
99
|
96
|
|
Stock
price went up :
|
54
|
46
|
| Stock
price went down : |
45
|
50
|
| |
|
|
|
Gain/Loss Ratio : |
1.2
|
1.2
|
| Percentage
Gain/Loss : |
 -16.7%
|
 8,928.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2023-06-27 |
34,370 |
2023-06-27 |
731,458 |
Premium* |
|
|
Dynatronics Corp |
DYNT |
10% Owner |
2017-03-21 |
500,000 |
2017-03-21 |
1,000,000 |
Premium* |
|
|
Kiora Pharmaceuticals |
KPRX |
10% Owner |
2021-01-06 |
3,346,601 |
2021-08-02 |
785,000 |
Premium* |
|
|
Fresh Tracks Therapeutics Ord Shs |
FRTX |
10% Owner |
2019-01-10 |
2,170,000 |
2019-01-10 |
2,170,000 |
Premium* |
|
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2018-02-06 |
6,936,000 |
2018-02-06 |
6,936,000 |
Premium* |
|
|
Cassava Sciences Inc |
SAVA |
10% Owner |
2018-10-03 |
1,651,340 |
2018-10-03 |
0 |
Premium* |
|
|
Del Friscos Restaurant Group, Llc |
DFRG |
10% Owner |
2019-09-25 |
0 |
2019-09-25 |
0 |
Premium* |
|
|
Valeritas Holdings Inc |
VLRX |
10% Owner |
2019-12-20 |
0 |
2019-12-20 |
0 |
Premium* |
|
|
Bio-Path Holdings, Inc. |
BPTH |
10% Owner |
2019-01-18 |
129,298 |
2019-01-18 |
129,298 |
Premium* |
|
|
AYTU BIOSCIENCE, INC |
AYTU |
Director |
2021-03-29 |
1,342,378 |
2021-03-29 |
1,342,378 |
Premium* |
|
|
Achieve Life Sciences Inc |
ACHV |
10% Owner |
2019-06-11 |
843,776 |
2019-06-11 |
843,776 |
Premium* |
|
|
AMAG Pharmaceuticals Inc |
AMAG |
10% Owner |
2020-03-16 |
4,120,000 |
2020-03-16 |
348,000 |
Premium* |
|
|
Onconova Therapeutics, Inc. |
ONTX |
10% Owner |
2019-09-23 |
816,702 |
2019-09-23 |
816,702 |
Premium* |
|
|
Vaxart Inc |
VXRT |
Director |
2020-06-29 |
145,523 |
2020-06-29 |
145,523 |
Premium* |
|
|
Tetraphase Pharmaceuticals Inc |
TTPH |
Director, 10% Owner |
2020-07-28 |
0 |
2020-07-28 |
0 |
Premium* |
|
|
Tenax Therapeutics Inc |
TENX |
Director, 10% Owner |
2020-09-08 |
2,019,995 |
2020-09-08 |
2,019,995 |
Premium* |
|
|
Cyclo Therapeutics, Inc |
CYTH |
10% Owner |
2020-09-30 |
15,795,769 |
2020-09-30 |
15,795,769 |
Premium* |
|
|
ReShape Lifesciences Inc |
RSLS |
10% Owner |
2021-06-28 |
7,223,346 |
2021-06-28 |
7,223,346 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
790 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 32 of 32
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AVTX |
Avalo Therapeutics, Inc |
Director |
– • • |
2021-01-08 |
4 |
B |
$2.60 |
$6,500,000 |
D/D |
2,500,000 |
32,634,285 |
3.92 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
10% Owner |
– – • |
2021-06-17 |
4 |
S |
$6.20 |
$6,934,172 |
D/D |
(1,106,210) |
791,456 |
0 |
% |
|
| KPRX |
Kiora Pharmaceuticals |
Director |
– • • |
2021-01-06 |
4 |
B |
$5.23 |
$8,000,003 |
D/D |
1,531,101 |
3,346,601 |
3.92 |
- |
|
| AYTU |
AYTU BIOSCIENCE, INC |
Director |
– • – |
2020-12-11 |
4 |
B |
$6.00 |
$8,000,004 |
D/D |
1,333,334 |
1,333,334 |
2.39 |
% |
|
| AVTX |
Avalo Therapeutics, Inc |
Director |
– • • |
2017-07-06 |
4 |
OE |
$0.35 |
$8,358,000 |
I/I |
23,880,000 |
15,324,224 |
0 |
- |
|
| AYTU |
AYTU BIOSCIENCE, INC |
Director |
– • – |
2020-04-27 |
4 |
S |
$1.82 |
$9,298,236 |
D/D |
(5,108,921) |
0 |
0 |
% |
|
| AVTX |
Avalo Therapeutics, Inc |
Director |
– • • |
2021-09-17 |
4 |
B |
$2.20 |
$11,999,999 |
I/I |
5,454,545 |
45,000,000 |
2.25 |
% |
|
| KPRX |
Kiora Pharmaceuticals |
Director |
– • • |
2021-07-27 |
4 |
S |
$3.80 |
$12,113,647 |
I/I |
(2,377,695) |
1,821,406 |
0 |
- |
|
| AVTX |
Avalo Therapeutics, Inc |
Director |
– • • |
2021-04-15 |
4 |
OE |
$2.00 |
$12,571,430 |
D/D |
6,285,715 |
38,920,000 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • • |
2020-04-30 |
4 |
S |
$2.96 |
$13,125,516 |
D/D |
(4,434,296) |
18,600,000 |
0 |
% |
|
| AYTU |
AYTU BIOSCIENCE, INC |
Director |
– • – |
2020-03-10 |
4 |
OE |
$0.00 |
$15,264,157 |
D/D |
15,229,161 |
22,026,802 |
0 |
- |
|
| AYTU |
AYTU BIOSCIENCE, INC |
Director |
– • – |
2020-03-10 |
4 |
S |
$0.99 |
$31,200,123 |
D/D |
(22,026,801) |
1 |
0 |
% |
|
| DFRG |
Del Friscos Restaurant Gr... |
10% Owner |
– – • |
2019-09-25 |
4 |
D |
$8.00 |
$49,000,000 |
D/D |
(6,125,000) |
0 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2020-06-29 |
4 |
S |
$8.29 |
$77,804,850 |
D/D |
(9,385,386) |
145,523 |
0 |
% |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2020-06-26 |
4 |
S |
$10.38 |
$189,192,803 |
D/D |
(18,226,667) |
5,440,000 |
0 |
% |
|
790 Records found
|
|
Page 32 of 32 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
